Taft partner Stephen Auten will present at the 2014 BIO International Convention in San Diego on June 26. His topic is “Predictions for the Future: Biopharmaceuticals and Exclusivity.”

Auten is head of Taft's Pharmaceutical and Life Sciences Litigation practice area. He is a widely recognized and seasoned attorney in Hatch-Waxman and biosimilar matters, including related patent litigation, and is followed by key industry leaders (brand and generic alike), law firms, analysts, educators and others on his LinkedIn blog "Hatch Waxman ANDA Litigation Forum," which has more than 5,000 members worldwide. He currently represents clients primarily in the areas of Paragraph IV design strategies, Hatch-Waxman litigation and biosimilar market opportunities.

To learn more about the program and register, please click here.